News
Imagine a drug that halts cancer without side effects or risks. That future may be a bit nearer thanks to recent research led ...
Research carried out on mice has revealed how a hormone released by the intestine acts on the brain and helps regulate the ...
Many people have that I-need-a-hug feeling these days. Here are surprising ways to stimulate the release of the feel-good ...
11h
GlobalData on MSNViking commences Phase III clinical programme of VK2735 for obesityViking Therapeutics has begun the VANQUISH Phase III clinical programme of the dual agonist of the glucagon-like peptide 1 ...
The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in ...
US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro, its widely used diabetes and weight-loss ...
17h
inews.co.uk on MSNHundreds of weight-loss and diabetes jab users report pancreas conditionHealth officials are launching a fresh study into their side effects after reported cases of pancreatitis, some of which have been fatal ...
Phase 3 Top Line Results Expected Q2 2026 SALT LAKE CITY, June 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN ), a biophar ...
A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...
(Reuters) -India’s drug regulator on Thursday approved the launch of pre-filled injector pens of Eli Lilly (NYSE: LLY )’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results